<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03477591</url>
  </required_header>
  <id_info>
    <org_study_id>4351</org_study_id>
    <nct_id>NCT03477591</nct_id>
  </id_info>
  <brief_title>Evaluating the Impact of Evidence-based Information About PSA Testing on Prostate Cancer Screening Decisions</brief_title>
  <official_title>McMaster Choices Study: Evaluating the Impact of Evidence-based Information About PSA Testing on Prostate Cancer Screening Decisions</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>McMaster University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Canadian Cancer Society Research Institute (CCSRI)</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>McMaster University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Patient decision aids are tools that help guide individuals through a healthcare-related
      decision making process. They help users combine evidence-based information and
      recommendations by a health care provider with their personal needs, values and preferences.
      Through this project, Dr. Dobbins and her research team will explore whether the use of
      patient decision aids with high-quality and user-friendly summaries of research evidence, or
      summaries of research evidence alone, help to improve the quality of decision making by men
      facing prostate cancer screening decisions.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Guidelines for prostate screening in Canada are based on low-moderate quality evidence of
      effectiveness and screening is associated with potential harms. Patient Decision Aids (PDAs)
      are tools that assist users to understand treatment options, risks and benefits to align
      decisions with values and preferences. The investigators would now like to know whether use
      of a PDA alongside evidence-based information provided through the McMaster Optimal Aging
      Portal, or simply access to evidence-based information alone, can help users to make informed
      decisions about prostate cancer screening in men.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">May 1, 2018</start_date>
  <completion_date type="Anticipated">March 1, 2019</completion_date>
  <primary_completion_date type="Anticipated">November 1, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Screening</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Decisional conflict</measure>
    <time_frame>Change from baseline to 6-mo</time_frame>
    <description>Decisional Conflict Scale</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Decision quality</measure>
    <time_frame>Change from baseline to 6-mo</time_frame>
    <description>Decision Quality Worksheet for PSA testing</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Preparation for decision making</measure>
    <time_frame>Change from baseline to 6-mo</time_frame>
    <description>Preparation for decision making scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Screening behaviour</measure>
    <time_frame>Change from baseline to 6-mo</time_frame>
    <description>Congruency between self-reported screening status and stated decision</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">308</enrollment>
  <condition>Prostate Cancer</condition>
  <arm_group>
    <arm_group_label>Evidence + PDA</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Evidence-based information on PSA testing such as blog posts, plain language evidence summaries and web resource ratings (quality-appraised online resources), plus a blog post on PDAs and the relevant decision aid from the Portal database</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Evidence only</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The same evidence-based information as group 1 (Evidence + PDA), but without the PDA to quantify the effect of accessing evidence through the Portal alone</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Attention control</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Information on how to distinguish high from low-quality health information, not specific to cancer screening or PDAs</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Evidence-based information</intervention_name>
    <description>Evidence-based information on PSA testing such as blog posts, plain language evidence summaries and web resource ratings (quality-appraised online resources).</description>
    <arm_group_label>Evidence + PDA</arm_group_label>
    <arm_group_label>Evidence only</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Patient Decision Aid</intervention_name>
    <description>Patient Decision Aid for prostate cancer screening decision</description>
    <arm_group_label>Evidence + PDA</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Sham information</intervention_name>
    <description>Educational information not specific to PSA testing or cancer screening</description>
    <arm_group_label>Attention control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  English speaking men, &gt; 50 years old

        Exclusion Criteria:

          -  History of prostate cancer or PSA test in the last 12 months
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Maureen Dobbins, RN, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>McMaster University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Sarah Neil-Sztramko, PhD</last_name>
    <phone>9055259140</phone>
    <phone_ext>20459</phone_ext>
    <email>neilszts@mcmaster.ca</email>
  </overall_contact>
  <location>
    <facility>
      <name>McMaster University</name>
      <address>
        <city>Hamilton</city>
        <state>Ontario</state>
        <zip>L8P0A1</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 12, 2018</study_first_submitted>
  <study_first_submitted_qc>March 19, 2018</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 26, 2018</study_first_posted>
  <last_update_submitted>March 19, 2018</last_update_submitted>
  <last_update_submitted_qc>March 19, 2018</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 26, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Screening</keyword>
  <keyword>PSA testing</keyword>
  <keyword>Patient Decision Aid</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Prostatic Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

